pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·2h ago·1 min read
save

Vaccine claims dominate federal autism advisory committee meeting, sidelining research funding plan

Aug 28, 2026·read at STAT ↗Negative

At a recent meeting of the federal autism advisory committee, members spent most of the time discussing vaccines as a possible trigger for autism.

The discussion eclipsed the committee’s intended agenda, which was to consider a proposal to increase federal funding for autism research.

Although the scientific consensus rejects a link between vaccines and autism, several public members cited vaccines and other factors such as glutamate or aspirin as potential causes, and the panel did not challenge those statements.

The strategic plan under review does not mention vaccines, highlighting a disconnect between the committee’s focus and its formal objectives.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Vaccines take center stage at federal autism advisory committee”

read at STAT ↗
510 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Ultragenyx Pharmaceutical Inc.
drugs
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE2SYNALGOS-DC2Stem Cell Therapy for Coronavirus Disease 2019 (COVID-19)2aspirin2
topics
Vaccines13AdCom5Psychiatry & CNS2ImmunologyRare Disease

related stories

  • Apr 28Predicting consequences of new hepatitis B vaccine recsSTAT
  • 1h agoSTAT+: In autopsy of failed heart disease study, AstraZeneca raises broader questions about silencer drugsSTAT
  • Aug 12STAT+: Definium Therapeutics says its LSD therapy eased anxiety in late-stage trialSTAT
  • Aug 6Opinion: One year since Kennedy canceled mRNA vaccine projects, science shows how wrong he wasSTAT
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive